Clinical Study
A Study of Single IV Dose of UX701 for Patients with Wilson Disease
UX701is a medication for patients with Wilson's disease. Research is needed to learn the safety and effectiveness of single IV doses of UX701. The information we gain may aid future patients.
For more information contact:
Srinivas Mulmalla
srinivas.mulamalla@hsc.utah.edu
801-581-7802
IRB#: IRB_00154398
| PI: Juan Gallegos-Orozco
| Department: GASTROENTEROLOGY
| Approval Date: 2022-12-07 07:00:00
Specialties: Gastroenterology
Who can participate?
Gender: All
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria:
- Ages 18 years and older
- Diagnosis of Wilson disease
- Stable Wilson disease
- In person at the University of Utah
Exclusion Criteria:
- Pregnant or breastfeeding
- Presence or history of a health issue(s) that may not allow participation
- Substance abuse 60 days before participation
- Moderate to severe depression
- History of liver transplant
Will I be paid for my time?
Yes